Natascha Kleiter
7. July 2018 2024-10-08 13:11Natascha Kleiter
Natascha Kleiter,
Section of Translational Cell Genetics,
Medical University InnsbruckTitle: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint
Section of Translational Cell Genetics,
Medical University InnsbruckTitle: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint
Natascha Kleiter has characterized NR2F6 as an intracellular immune checkpoint, directly repressing transcription of cytokine genes in T cells relevant for cancer cell rejection and therefore enhancing tumor immune surveillance.
https://phd-school.i-med.ac.at/phd-programs/doctoralprogram/molecular-cell-biology
Related Posts
Ulrich Kalinke
15. June 2023
616 views
Burkhard Ludewig
28. April 2023
740 views
Clemens Schmitt
22. September 2022
683 views
Matthias Ernst
2. June 2022
643 views
Werner Held
22. April 2022
615 views
Search
Categories